Category: Pharmaceutical
-
India’s Next Pharma Chapter: From Generics Giant to Innovation Powerhouse
For decades, India’s pharmaceutical identity has been shaped by one defining phrase: “The pharmacy of the world.” With over 60% of global vaccine supply and nearly 20% of generic medicines consumed worldwide manufactured in India, the narrative has been firmly established. But history shows that industrial reputation is rarely static.…
-
Re-shoring the Future: How Pharma’s Return to U.S. Soil Redefines the Global Biotech Map
The New Geography of Medicine The global pharmaceutical and biotechnology industries are entering a new phase of geographic realignment. Major companies such as Biogen, Merck, and Amgen have recently announced multi-billion-dollar investments to expand their U.S. manufacturing bases—particularly in biologics, gene therapies, and advanced therapeutics.This trend, described by analysts as…
-
Pharma Exports and Trade Diversification: India’s Strategic Pivot Beyond the U.S.
India’s pharmaceutical sector has long enjoyed a dominant export relationship with the United States, its largest and most lucrative market. In FY2025 alone, Indian pharma exports to the U.S. crossed $10.5 billion, cementing America’s role as the cornerstone of India’s global pharma trade. However, persistent concerns about tariff escalations and…
-
Trump’s Pharma Tariffs: A New Flashpoint in US-India Trade Tensions
President Donald Trump’s latest tariff announcement marks one of the most aggressive trade policy moves in recent years, setting the stage for a potential economic and diplomatic standoff between the United States and India. The policy introduces phased tariffs on imported pharmaceuticals, starting at a modest level but with the…
-
Pharmaceuticals and Biotechnology in 2025: Where Science Meets Innovation
In 2025, the global pharmaceuticals and biotechnology industry is at the forefront of a healthcare revolution. With breakthroughs in genomics, artificial intelligence (AI), and personalized medicine, the sector is no longer just about curing disease—it is about preventing, predicting, and tailoring treatment to individual patients. The convergence of life sciences…
-
Healthcare and Pharma: Driving Forces Behind a Transforming Industry
Healthcare and pharmaceuticals remain pivotal sectors in the global economy, increasingly shaped by innovation, demographic shifts, and policy priorities. The continuous growth trajectory of this industry is not merely a function of market size, but a reflection of the evolving needs and behaviors of populations worldwide. Global Demand and Demographic…
-
Indian Pharmaceuticals: Resilience Amid Global Trade Turbulence
The ongoing tariff conflict , reignited by the recent aggressive trade stance, has sent tremors through global markets. However, amidst this chaos, India’s pharmaceutical industry appears to be standing firm, largely shielded from the immediate brunt of new U.S. tariffs. This strategic exemption underscores not only the indispensability of Indian…
-
Pharmaceutical Manufacturing in India: The Growing Concern of API Import Dependence
India, known as the “pharmacy of the world,” plays a pivotal role in global pharmaceutical manufacturing. From generic drugs to essential vaccines, the country’s pharmaceutical sector is a crucial part of both the domestic and international healthcare landscapes. However, beneath this success story lies a critical vulnerability: India’s heavy dependence…